Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Bluthgen, MV"'
Autor:
Remon, J, Caramella, C, Jovelet, C, Lacroix, L, Lawson, Andrew, Smalley, S, Howarth, K, Gale, Davina, Green, E, Plagnol, V, Rosenfeld, Nitzan, Planchard, D, Bluthgen, MV, Gazzah, A, Pannet, C, Nicotra, C, Auclin, E, Soria, JC, Besse, B
Background: Approximately 50% of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients treated with EGFR tyrosine kinase inhibitors (TKIs) will acquire resistance by the T790M mutation. Osimertinib is the standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::218c824277d1fafe61b827249ca91669
Autor:
Seguí E; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Torres JM; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Auclin E; Department of Medical Oncology, Hopital Europeen George Pompidou, AP-HP, Université Paris Cité, 75015 Paris, France., Casadevall D; Department of Medical Oncology, Hospital del Mar, 08036 Barcelona, Spain., Peiro Carmona S; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Aguilar-Company J; Department of Medical Oncology, Vall d'Hebron University Hospital, 08036 Barcelona, Spain., García de Herreros M; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Gorría T; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Laguna JC; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Rodríguez M; Department of Medical Oncology, Vall d'Hebron University Hospital, 08036 Barcelona, Spain.; Department of Medical Oncology, Parc Taulí Hospital Universitari, 08208 Sabadell, Spain., González A; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Epaillard N; Department of Medical Oncology, Hopital Europeen George Pompidou, AP-HP, Université Paris Cité, 75015 Paris, France., Gavira J; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08036 Barcelona, Spain., Bolaño V; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Tapia JC; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08036 Barcelona, Spain., Tagliamento M; Department of Internal Medicine and Medical Specialties, University of Genova, 16126 Genova, Italy.; Academic Medical Oncology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy., Teixidó C; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Pathology and CORE Molecular Biology laboratory, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain., Arasanz H; Department of Medical Oncology, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain., Pilotto S; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy., Lopez-Castro R; Department of Medical Oncology, Hospital Clinico Universitario de Valladolid, 47003 Valladolid, Spain., Mielgo-Rubio X; Department of Medical Oncology, Hospital Universitario Fundación Alcorcon, 28922 Alcorcon, Spain., Urbano C; Department of Medical Oncology, Hospital General de Granollers, 08402 Granollers, Spain., Recondo G; Department of Medical Oncology, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC), Buenos Aires C1000, Argentina., Diaz Pavon M; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Bluthgen MV; Department of Medical Oncology, Hospital Aleman, Buenos Aires C1118AAT, Argentina., Minatta JN; Department of Medical Oncology, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina., Lupinacci L; Department of Medical Oncology, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.; Institute of Oncology (IOB)-Hospital Quirón Salud, 08023 Barcelona, Spain.; Reveal Genomics, 08036 Barcelona, Spain., Vlagea A; Department of Immunology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Mezquita L; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 26; Vol. 16 (17). Date of Electronic Publication: 2024 Aug 26.
Autor:
Rizzo MM; Hospital Universitario Austral, Av. Pte. Perón 1500, Derqui, Pilar, Buenos Aires, Argentina. mangliorizzo@gmail.com., Bluthgen MV; Hospital Alemán, CABA, Av. Pueyrredón 1640, Buenos Aires, Argentina., Recondo G; Centro de Educación Médica E Investigaciones Clínicas (CEMIC). Av. Gral. Las Heras 2900, CABA, Buenos Aires, Argentina., Naveira M; Hospital Británico de Buenos Aires, CABA, Perdriel 74, Buenos Aires, Argentina., Perfetti A; Hospital Donación Francisco Santojanni, Pilar 950, Buenos Aires, Argentina., Rizzi F; Hospital Alemán, CABA, Av. Pueyrredón 1640, Buenos Aires, Argentina., Kuzminin A; Centro de Educación Médica E Investigaciones Clínicas (CEMIC). Av. Gral. Las Heras 2900, CABA, Buenos Aires, Argentina., Faura V; Hospital Británico de Buenos Aires, CABA, Perdriel 74, Buenos Aires, Argentina., Cerini M; Hospital Italiano de Buenos Aires, CABA, Pres. Tte. Gral. Juan Domingo Perón, 4190, Buenos Aires, Argentina., Videla A; Hospital Universitario Austral, Av. Pte. Perón 1500, Derqui, Pilar, Buenos Aires, Argentina., Silva C; Hospital Universitario Austral, Av. Pte. Perón 1500, Derqui, Pilar, Buenos Aires, Argentina., Lupinacci L; Hospital Italiano de Buenos Aires, CABA, Pres. Tte. Gral. Juan Domingo Perón, 4190, Buenos Aires, Argentina., Minatta N; Hospital Italiano de Buenos Aires, CABA, Pres. Tte. Gral. Juan Domingo Perón, 4190, Buenos Aires, Argentina.
Publikováno v:
International journal of clinical oncology [Int J Clin Oncol] 2021 Jun; Vol. 26 (6), pp. 1057-1064. Date of Electronic Publication: 2021 Mar 14.
Autor:
Molina TJ; Department of Pathology, AP-HP, INSERM U1163, Institut Imagine, Hôpital Universitaire Necker-Enfants-Malades, Université de Paris, Paris, France. Electronic address: thierry.molina@aphp.fr., Bluthgen MV; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Chalabreysse L; Department of Pathology, Groupement Hospitalier Est, Hospices Civils de Lyon, France., de Montpréville VT; Department of Pathology, Institut d'oncologie thoracique, Hôpital Marie-Lannelongue, Le Plessis-Robinson, France., de Muret A; Department of Pathology, CHU de Tours, France., Dubois R; Institute of Pathology, CHU de Lille, France., Hofman V; University Côte d'Azur, Laboratory of Clinical and Experimental Pathology, FHU OncoAge, Pasteur Hospital, Biobank, 0033-00025, Nice, France., Lantuejoul S; Department of BioPathology, CHU de Centre Léon Bérard, Lyon, and Grenoble Alpes University, Grenoble, France., le Naoures C; Department of pathology, CHU Rennes, Rennes, France., Mansuet-Lupo A; Department of Pathology, AP-HP, INSERM U1138, Centre de Recherche des Cordeliers, Hôpital Universitaire Cochin, Université de Paris, Paris, France., Parrens M; Department of Pathology, CHU de Bordeaux, INSERM U1053, Université de Bordeaux, 146 rue Léo Saignat, 33076, Bordeaux, France., Piton N; Rouen University Hospital, Department of Pathology, F 76 000, Rouen, France., Rouquette I; Department of Pathology, CHU Toulouse Oncopole, 1 avenue I Joliot Curie, 31059, Toulouse, France., Secq V; Department of Pathology, Hôpital Nord, AP-HM, Marseille, France., Girard N; Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Lyon, France; Institut Curie, Paris, France., Marx A; Institute of Pathology, Mannheim Medical University, Heidelberg University, Mannheim, Germany., Besse B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jan; Vol. 143, pp. 158-167. Date of Electronic Publication: 2020 Dec 11.
Autor:
Dormieux A; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Mezquita L; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Cournede PH; MICS laboratory, CentraleSupélec, Université Paris-Saclay, Gif-sur-Yvette, France., Remon J; Medical Oncology Department, Centro Integral Oncología Clara Campal Bacelona, HM-Delfos, Barcelona, Spain., Tazdait M; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Lacroix L; Molecular Biology Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Rouleau E; Molecular Biology Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Adam J; Pathology Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Bluthgen MV; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Facchinetti F; Research Department (U981), Gustave Roussy Cancer Campus, Université Paris-Saclay, F-94805, Villejuif, France., Tselikas L; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Aboubakar F; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Naltet C; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Lavaud P; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Gazzah A; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Le Pechoux C; Radiation Therapy Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Lassau N; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France.; IR4M, UMR 8081, CNRS, Université Paris-Saclay, F-91400, Orsay, France., Balleyguier C; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France.; IR4M, UMR 8081, CNRS, Université Paris-Saclay, F-91400, Orsay, France., Planchard D; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Besse B; Cancer Medicine Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France., Caramella C; Imaging Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France. caroline.caramella@gustaveroussy.fr.; IR4M, UMR 8081, CNRS, Université Paris-Saclay, F-91400, Orsay, France. caroline.caramella@gustaveroussy.fr.; Radiology Department, Gustave Roussy, 114 Rue Édouard-Vaillant, 94805, Villejuif Cedex, France. caroline.caramella@gustaveroussy.fr.
Publikováno v:
European radiology [Eur Radiol] 2020 Sep; Vol. 30 (9), pp. 5021-5028. Date of Electronic Publication: 2020 Apr 23.
Autor:
Bluthgen MV; Medical Oncology, Hospital Alemán de Buenos Aires, 1118, Argentina., Basté N; Medical Oncology, Hospital Clinic de Barcelona, 08036, Spain., Recondo G; Medical Oncology, Centro de Educación Médica e Investigaciones Clinicas (CEMIC), Buenos Aires 1431, Argentina.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2020 Aug; Vol. 16 (23), pp. 1715-1736. Date of Electronic Publication: 2020 Jun 05.
Autor:
Noël N; Assistance Publique - Hôpitaux de Paris, Hopital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; INSERM, U1184, Immunologie des Maladies Virales et Autoimmunes, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, Département d'Immunovirologie, IDMIT, F-92265 Fontenay-aux-Roses, France., Le Roy A; Assistance Publique - Hôpitaux de Paris, Hopital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275 Le Kremlin-Bicêtre, France; Ecole du Val de Grâce, 1 place Alphonse Laveran, F-75005 Paris, France., Hot A; Service de Médecine Interne, Hopital Edouard Herriot, F-69003 Lyon, France., Saadoun D; Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005 Paris, France; INSERM, UMR_S 959, F-75013 Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013 Paris, France; CNRS, FRE3632, F-75005 Paris, France; Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, Centre de Référence des Maladies Auto-Inflammatoires et de l'Amylose, France., Lazaro E; Service de Médecine Interne, Hopitaux Universitaires de Bordeaux, Hopital Haut-Lévêque, F-33604 Pessac, France., Lévesque H; Normandie univ, UNIROUEN, U1096, Service de Médecine Interne, F-76000 Rouen, France., Le Gouellec N; Service de Médecine Interne, Hopital de Valenciennes, F-59300 Valenciennes, France., Meaux-Ruault N; Service de Médecine Interne, CHU de Besançon, Hopital Jean Minjoz, 3 boulevard Fleming, F-25030 Besançon, France., Nguyen T; Service de Cancérologie, CHU de Besançon, Hopital Jean Minjoz, 3 boulevard Fleming, F-25030 Besançon, France., Costedoat-Chalumeau N; APHP, Service de Médecine Interne, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, F-75014 Paris, France., Amieux B; Rhumatologie, F- 69003 Lyon, France., Fontana A; Service de Rhumatologie, Pavillon F, CHU Édouard Herriot, F-69003 Lyon, France., De Gennes C; APHP, Service de Médecine Interne, Hôpital Pitié-Salpétrière, F-75013 Paris, France., Fulpin J; Rhumatologie, F-83200 La Crau, France., Thomas PA; Service de Chirurgie Thoracique, CHU Nord, F-13915 Marseille cedex 20, France., Bluthgen MV; Cancer Medicine Department, Gustave Roussy, F-94800 Villejuif, France., Besse B; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; Cancer Medicine Department, Gustave Roussy, F-94800 Villejuif, France., Lambotte O; Assistance Publique - Hôpitaux de Paris, Hopital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; INSERM, U1184, Immunologie des Maladies Virales et Autoimmunes, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, Département d'Immunovirologie, IDMIT, F-92265 Fontenay-aux-Roses, France. Electronic address: olivier.lambotte@aphp.fr.
Publikováno v:
Autoimmunity reviews [Autoimmun Rev] 2020 Mar; Vol. 19 (3), pp. 102464. Date of Electronic Publication: 2020 Jan 07.
Autor:
Rouquette I; 1IUCT-Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse, France., Taranchon-Clermont E; 1IUCT-Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse, France., Gilhodes J; 1IUCT-Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse, France., Bluthgen MV; 2Gustave Roussy, 114 rue E Vaillant, 94805 Villejuif, France., Perallon R; 1IUCT-Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse, France., Chalabreysse L; 3HCL, Hôpital Louis Pradel, 28 Avenue du Doyen Jean Lépine, 69500 Bron, France., De Muret A; Hôpital Trousseau, Avenue de la République, 37170 Chambray-lès-Tours, France., Hofman V; 5Hôpital Pasteur CHU, 30 voie Romaine, 06000 Nice, France., Marx A; Institut de Pathologie, Universitaetsmedizin Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Parrens M; 7Hôpital Haut-Levêque CHU, Avenue de Magellan, 33604 Pessac, France., Secq V; 8APHM Hôpital Nord, Chemin des Bourrely, 13915 Marseille, France., Thomas de Montpreville V; 9Centre Chirurgical Marie-Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis- Robinson, France., Galateau-Salle F; 10Centre Léon Bérard, 28 rue Laennec -, 69008 Lyon, France., Brousset P; 1IUCT-Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse, France., Milia J; 11Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, 24 Chemin de Pouvourville, 31059 Toulouse, France., Girard N; 12Institut du Thorax Curie Montsouris, Institut Curie, 26, Rue d'Ulm, 75005 Paris, France., Besse B; 13Gustave Roussy, 114 rue E Vaillant, 94805 Villejuif, France.; 14Paris-Sud university, Orsay, France., Molina TJ; Hôpital Necker Enfants Malades, AP-HP, Université de Paris, 149 Rue de Sèvres, 75015 Paris, France., Mazières J; 11Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, 24 Chemin de Pouvourville, 31059 Toulouse, France.
Publikováno v:
Biomarker research [Biomark Res] 2019 Dec 04; Vol. 7, pp. 28. Date of Electronic Publication: 2019 Dec 04 (Print Publication: 2019).
Autor:
Mezquita L; Medical Oncology Department, Gustave Roussy, Villejuif, France., Charrier M; Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France., Faivre L; Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Dupraz L; Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France., Lueza B; Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Oncostat CESP, INSERM, Université Paris-Saclay, University Paris-Sud, UVSQ, Villejuif, France., Remon J; Medical Oncology Department, Gustave Roussy, Villejuif, France., Planchard D; Medical Oncology Department, Gustave Roussy, Villejuif, France., Bluthgen MV; Medical Oncology Department, Gustave Roussy, Villejuif, France., Facchinetti F; Medical Oncology Department, Gustave Roussy, Villejuif, France., Rahal A; Medical Oncology Department, Gustave Roussy, Villejuif, France., Polo V; Medical Oncology Department, Gustave Roussy, Villejuif, France., Gazzah A; Drug Development Department, Gustave Roussy, Villejuif, France., Caramella C; Radiology Deparment, Gustave Roussy, Villejuif, France., Adam J; Pathology Department, Gustave Roussy, Villejuif, France., Pignon JP; Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Oncostat CESP, INSERM, Université Paris-Saclay, University Paris-Sud, UVSQ, Villejuif, France., Soria JC; Drug Development Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France., Chaput N; Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France., Besse B; Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address: benjamin.besse@gustaveroussy.fr.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Oct; Vol. 112, pp. 10-15. Date of Electronic Publication: 2017 Jul 29.
Autor:
Facchinetti F; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: Francesco.FACCHINETTI@gustaveroussy.fr., Bluthgen MV; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: mvbluthgen@gmail.com., Tergemina-Clain G; Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: gabrielle.clain@gmail.com., Faivre L; Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: laura4.faivre@gmail.com., Pignon JP; Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: Jean-Pierre.PIGNON@gustaveroussy.fr., Planchard D; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: David.PLANCHARD@gustaveroussy.fr., Remon J; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: jremon@vhio.net., Soria JC; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: Jean-Charles.SORIA@gustaveroussy.fr., Lacroix L; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France; Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France; Genomic platform, Molecular Biopathology Unit and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, University Paris XI, Gustave Roussy, Villejuif, France. Electronic address: Ludovic.LACROIX@gustaveroussy.fr., Besse B; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: Benjamin.Besse@gustaveroussy.fr.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Oct; Vol. 112, pp. 62-68. Date of Electronic Publication: 2017 Aug 07.